Pharmafile Logo
Pharmafocus logo
Advanced Search

Seroxat

Showing 6 posts of 6 posts found.

gsk_boronia_australia

GSK loses £37m appeal over pay-to-delay tactics to block Seroxat competition

March 9, 2018
Medical Communications, Sales and Marketing GSK, Pay to delay, Seroxat, antidepressant, pay-to-delay, pharma

GlaxoSmithKline has suffered a sizeable blow after losing an appeal disputing that it had engaged in anti-competitive pay-to-delay tactics to …

News
GSK image

GSK cancels sale of established products

December 5, 2014
Medical Communications, Sales and Marketing FDA, GSK, Paxil, Seroxat, Zantac, bribery, cuts, imitrex

GlaxoSmithKline has decided not to sell off several of its ageing brands in the face of continuing business problems. The …

News
gsk image

GSK sales up – impact of China allegations to follow

July 24, 2013
Sales and Marketing GSK, Q2, Seretide, Seroxat, Witty, bribery, transparency

GlaxoSmithKline has reported a modest rise in sales but the fallout from China’s bribery probe dominates the firm’s release of …

News
GSK image

China accuses GSK of large scale bribery

July 12, 2013
Medical Communications, Research and Development, Sales and Marketing Avandia, China, GSK, Seroxat

Health officials in China say they have found evidence GSK tried to generate sales and raise drug prices by bribing …

News
GSK image

GSK faces £2.6 billion fine

April 19, 2013
Sales and Marketing GSK, Seroxat, paroxetine

GlaxoSmithKline could be fined £2.6 billion after the Office of Fair Trading (OFT) alleged it paid generics firms to slow …

News

GSK takes £1.58bn hit from legal disputes

July 16, 2010
Sales and Marketing Avandia, GlaxoSmithKline, Paxcil, Seroxat

GlaxoSmithKline is set to pay £1.58 billion to settle three long-standing legal disputes, including litigation costs for its troubled diabetes …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024